Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator

Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator

<p>Abstract</p> <p>Background</p> <p>Immunological prevention of cancer has been obtained in HER-2/neu transgenic mice using a vaccine that combines 3 different immune stimuli (Triplex vaccine) that is repeatedly administered for the entire lifespan of the host (Chronic...

Full description

Bibliographic Details
Main Authors:	Motta Santo, Lollini Pier-Luigi, Pappalardo Francesco
Format:	Article
Language:	English
Published:	BMC 2006-07-01
Series:	BMC Bioinformatics
Online Access:	http://www.biomedcentral.com/1471-2105/7/352

Similar Items

Virus-like antigen display for cancer vaccine development, what is the potential?
by: Adam F. Sander, et al.
Published: (2018-04-01)

The Promise of Preventive Cancer Vaccines
by: Pier-Luigi Lollini, et al.
Published: (2015-06-01)

Optimal vaccination schedule search using genetic algorithm over MPI technology
by: Calonaci Cristiano, et al.
Published: (2012-11-01)

ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization.
by: Pappalardo, F, et al.
Published: (2009)

Optimized grid resource discovery based on ant-like mobile agent and genetic algorithm /
by: Hossein Boroumand Noghabi, 1978- , author, et al.
Published: (2014)

Optimized grid resource discovery based on ant-like mobile agent and genetic algorithm /
by: Hossein Boroumand Noghabi, 1978- , author
Published: (2014)

Preclinical HER-2 vaccines: from rodent to human HER-2
by: Pier-Luigi eLollini, et al.
Published: (2013-06-01)

Genetic Algorithms for the Discovery of Homogeneous Catalysts
by: Simone Gallarati, et al.
Published: (2023-02-01)

Smart driving simulation using agent approach
by: Abdullah, Nurul Azma, et al.
Published: (2008)

Parallelisation strategies for agent based simulation of immune systems
by: Mozhgan Kabiri Chimeh, et al.
Published: (2019-12-01)

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
by: Francesca Ruzzi, et al.
Published: (2023-08-01)

Cancer immunoprevention: from mice to early clinical trials
by: Arianna Palladini, et al.
Published: (2018-06-01)

Simulation environment for algorithms and agents evaluation.
by: Pablo CHAMOSO, et al.
Published: (2016-06-01)

i-Saturate: The New Discovery of Stopping Criterion in Genetic Algorithm
by: Foo, Fong Yeng, et al.
Published: (2020)

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
by: Carla De Giovanni, et al.
Published: (2019-04-01)

Explaining a Deep Reinforcement Learning (DRL)-Based Automated Driving Agent in Highway Simulations
by: Francesco Bellotti, et al.
Published: (2023-01-01)

Protocols in drug discovery
by: Adam Zweifach
Published: (2023-03-01)

Simulator motion-drive algorithms : a designer's perspective /
by: 389112 Nahon, Meyer A., et al.

Emerging Cancer Vaccines: The Promise of Genetic Vectors
by: Gennaro Ciliberto, et al.
Published: (2011-09-01)

Driving Model of Electronic Information System Based on Agent Modeling and Simulation
by: Lei Junli
Published: (2023-07-01)

Agent discovery in mobile ip /
by: 354387 Chai, Ai Ssa
Published: (2001)

Antiviral Agents: Discovery to Resistance
by: Catherine S. Adamson
Published: (2020-04-01)

ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale.
by: Halling-Brown, M, et al.
Published: (2010)

Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research
by: Lorena Landuzzi, et al.
Published: (2023-01-01)

Partitioning algorithms for agent-based crowd simulation
by: Wang, Yongwei
Published: (2011)

Agent-Based Simulations Using Genetic Algorithm Calibration: A Children’s Services Application
by: Luke White, et al.
Published: (2022-01-01)

Genetic Algorithm-Based Commutation Angle Control for Torque Ripple Mitigation in Switched Reluctance Motor Drives
by: Renata Rezende C. Reis, et al.
Published: (2023-01-01)

Simulation Study of the Variations in Driving Pressure and Frequency on Microbubbles Contras Agents Behavior
by: Aladdin M. Hasson, et al.
Published: (2017-08-01)

African Early Infection Cohort as a Platform for Vaccine Discovery: The IAVI Protocol C Experience.
by: Gilmour, J, et al.
Published: (2014)

Adaptive genetic algorithm for user preference discovery in multi-criteria recommender systems
by: Mohammed Wasid, et al.
Published: (2023-07-01)

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
by: Lorena Landuzzi, et al.
Published: (2021-02-01)

Reducing contrast agent residuals in hospital wastewater: the GREENWATER study protocol
by: Moreno Zanardo, et al.
Published: (2023-05-01)

A Recent Achievement in the Discovery and Development of Vaccines and Therapeutic Agents in the Race for COVID-19 Protection and Treatment
by: Zemene Demelash Kifle MSc, et al.
Published: (2021-03-01)

The discovery of the foxglove as a therapeutic agent
by: Aronson, J
Published: (1987)

Agent discovery in mobile ip [microfilm] /
by: Chai, Ai Ssa
Published: (2001)

Discovery of Benzopyrrolizidines as Promising Antigiardiasic Agents
by: Juan Carlos Auriostigue-Bautista, et al.
Published: (2022-01-01)

The Discovery of Druggable Anti-aging Agents
by: Gulperi Yalcin, et al.
Published: (2020-12-01)

Genetic algorithms in optimisation, simulation and modelling /
by: Stender, J. (Joachim), et al.
Published: (1994)

Computational discovery of vaccine targets
by: Zhang, Guang Lan
Published: (2008)

The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?
by: Giuseppe Lamberti, et al.
Published: (2020-10-01)